je.st
news
FDA panel backs first-in-class cholesterol drug
2015-06-10 01:17:06| Biotech - Topix.net
Federal health advisers on Tuesday recommended approval for a highly-anticipated cholesterol drug from Sanofi and Regeneron Pharmaceuticals, but with the caveat that more data is needed about its long-term ability to reduce heart attacks. The expert panel recommended by a 13-3 vote that the Food and Drug Administration approve the injectable drug, called Praluent.
Tags: panel
drug
backs
cholesterol
Category:Biotechnology and Pharmaceuticals